Evidence mapPaperPMID 40065337Full record

ArticleCardiovascular diabetology2025

Can cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance?

Jiajun Qiu, Jin'e Li, Shan Xu, Haixia Zeng, Yuying Zhang, Shiqi Yang, Lixuan Fang, Jiadian Huang, Hongtao Zhou, Jiaying Feng and 2 more

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiajun QiuDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Jin'e LiDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Shan XuDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Haixia ZengBranch of National Clinical Research Center for Metabolic Diseases, Nanchang, 330006, Jiangxi, China.
Yuying ZhangDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Shiqi YangDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Lixuan FangDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Jiadian HuangDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Hongtao ZhouDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Jiaying FengDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Yujie ZhanDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
Jianping LiuDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China. ndefy14105@ncu.edu.cn.

Funding

Jiangxi Province Key Laboratory of Molecular Medicine No.2024SSY06231Key Research, Development Program of Jiangxi Province 20243BBI91008National Natural Science Foundation of China Grant No.82160162Project of the Second Affiliated Hospital of Nanchang University 2022efyA04
6 · The paper itself

Abstract

backgroundInsulin resistance(IR) is associated with an increased risk of all-cause and cardiovascular death, and modifiable healthy lifestyles play an active role in the improvement of IR and the reduction of all-cause and cardiovascular death. Whether cardiovascular health (CVH) and modifiable healthy lifestyles within it can attenuate or even offset the heightened perils of both all-cause and cardiovascular deaths associated with insulin resistance remains unclear.

methodsThe study encompassed 14,172 healthy participants from the 2005-2018 NHANES programme. Insulin resistance was evaluated using the TyG index, TyG-WC, and TyG-WHtR, while CVH was assessed employing the LE8 score, in addition to the LE4 index redefined according to four health behaviours. Weighted multifactor Cox regression models were used to assess the association of IR and CVH with all-cause and cardiovascular mortality, and dose-response relationships were assessed using restricted cubic spline. Furthermore, subjects were grouped according to IR and CVH scores, and generalised linear models were used to estimate the weighted mortality and risk of death for each group and to calculate the absolute risk difference. Finally, the predicted probability of all-cause and cardiovascular mortality risk as a function of IR was computed, and the complex relationship between the three was visualised using two-dimensional grouped scatter plots and three-dimensional surface plots.

resultsAmong the 14,172 healthy participants included in the study, 1534 deaths occurred over a mean follow-up period of 7.6 years (382 of these deaths were due to cardiovascular causes). The weighted Cox regression analysis indicated that elevated TyG-WC and TyG-WHtR correlated with a greater likelihood of mortality from all causes and cardiovascular events, whereas cardiovascular health was inversely associated with these risks. Additional stratification revealed a notable reduction in the likelihood of mortality from all causes and cardiovascular events as cardiovascular health improved, irrespective of the presence of insulin resistance. Additionally, participants with high insulin resistance but moderate or high cardiovascular health did not have significantly increased risks compared with those with low insulin resistance. Stratified scatter plots and 3D surface plots revealed that cardiovascular health and modifiable healthy lifestyles significantly reduced the risk of insulin resistance-related death, with greater reductions observed at higher insulin resistance levels.

conclusionsIn this cohort study, improving cardiovascular health and modifiable health behaviors significantly reduced the risk of insulin resistance-related all-cause and cardiovascular deaths. Maintaining cardiovascular health at moderate or high levels (LE8 ≥ 50) could offset the increased risks caused by insulin resistance.

Indexed as

Cardiovascular DiseasesHealthy LifestyleInsulin ResistanceRisk Reduction BehaviorAdultAgedBiomarkersBlood GlucoseCause of DeathCross-Sectional StudiesFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedNutrition SurveysBiomarkersBlood GlucoseAll-cause deathCardiovascular deathCardiovascular healthInsulin resistanceTyG indexTyG-WCTyG-WHtR

Identifiers

PMID40065337
PMCPMC11895255

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.